Quadrature Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.5M Buy
830,712
+160,621
+24% +$8.72M 0.3% 71
2026
Q1
$42M Buy
+670,091
New +$53.6M 0.5% 44
2025
Q4
Sell
-30,127
Closed -$2.94M 1279
2025
Q3
$2.94M Sell
30,127
-77,751
-72% -$8.05M 0.03% 247
2025
Q2
$11.6M Sell
107,878
-117,718
-52% -$11.9M 0.2% 108
2025
Q1
$22.7M Buy
225,596
+205,915
+1,046% +$20.7M 0.5% 45
2024
Q4
$1.76M Sell
19,681
-37,578
-66% -$3.31M 0.04% 326
2024
Q3
$4.8M Buy
+57,259
New +$4.51M 0.11% 150
2023
Q3
Sell
-12,462
Closed -$674K 1008
2023
Q2
$674K Buy
+12,462
New +$651K 0.01% 507
2021
Q1
Sell
-267,731
Closed -$9.63M 886
2020
Q4
$9.63M Buy
267,731
+32,936
+14% +$1.19M 0.47% 44
2020
Q3
$8.97M Buy
234,795
+187,922
+401% +$7.24M 0.52% 46
2020
Q2
$1.65M Buy
+46,873
New +$1.69M 0.19% 166
2020
Q1
Sell
-41,802
Closed -$1.89M 518
2019
Q4
$1.89M Buy
+41,802
New +$1.75M 0.07% 220
2018
Q1
Sell
-40,705
Closed -$1.01M 602
2017
Q4
$1.01M Buy
+40,705
New +$1.12M 0.09% 219
2016
Q4
Sell
-402,560
Closed -$9.58M 623
2016
Q3
$9.58M Buy
+402,560
New +$9.6M 0.83% 23

Other funds holding BSX

Quadrature Capital's BSX Position: Q2 2026 in Review

Quadrature Capital increased its Boston Scientific (BSX) stake by 24% in Q2 2026, buying an estimated $8.72M and bringing the position to 830,712 shares worth $35.5M. The position accounts for 0.3% of the portfolio, ranked #71.

Quadrature Capital first reported a position in BSX in Q3 2016 and has held it in 14 quarters since. The position peaked at $42M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Quadrature Capital held 830,712 shares of Boston Scientific worth $35.5M as of Q2 2026.
  • Quadrature Capital bought 160,621 Boston Scientific shares in Q2 2026, an estimated $8.72M.
  • Boston Scientific made up 0.3% of Quadrature Capital's portfolio in Q2 2026, its #71 holding.
  • Quadrature Capital first reported a position in Boston Scientific in Q3 2016 and has held it in 14 quarters since.
  • Quadrature Capital's Boston Scientific position peaked at $42M in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.